medmix' Drug Delivery ("Haselmeier") to Support the Development of Xeris Pharmaceuticals' XP-8121 with D-Flex(TM) Pen Injector
DOWNLOAD MEDIA RELEASE Baar, Switzerland--(. - September 10, 2026) - medmix’ Drug Delivery (“Haselmeier”) announces its collaboration with Xeris Pharmaceuticals to support the development of Xeris’ XP-8121 product candidate, an investigational once-weekly subcutaneous levothyroxine the…
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.